Enterprise AI Analysis
Antiviral activity and chemical characterization of Egyptian Ziziphus spina-christi against human respiratory viruses
This AI-driven analysis distills critical insights from the research paper, highlighting key findings, enterprise applications, and potential ROI.
Executive Impact: Ziziphus spina-christi as a Natural Antiviral Solution
This comprehensive analysis of Egyptian Ziziphus spina-christi reveals its significant antiviral capabilities against influenza virus H1N1, MERS-CoV, and SARS-CoV-2. Crude leaf extracts demonstrated potent activity with an IC50 of 1.240 µg/ml for H1N1 and 7.397 µg/ml for SARS-CoV-2, while residual leaf extracts showed a remarkable IC50 of 1.501 µg/ml against MERS-CoV. The primary mode of action identified is virucidal, directly inactivating viruses. Molecular docking highlighted Lotoside II and Hydroxygenistein methyl ether malonylhexoside as key compounds exhibiting strong binding affinities to viral targets. These findings position Z. spina-christi as a promising natural source for novel, cost-effective antiviral treatments, offering a significant pathway for new drug development in the fight against prevalent respiratory infections.
0
H1N1 IC50 (Crude Leaf)
0
MERS-CoV IC50 (Residual Leaf)
0
SARS-CoV-2 Spike Binding
0
Max Virucidal Inhibition
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Chemical Composition
Antiviral Efficacy (In Vitro)
Mechanism of Action (In Silico)
Identified Bioactive Compounds
Flavonoids, phenolic acids, saponins, sterols, and triterpenes and their glucosides were the major detected compounds in both leaf and fruit fractions and extracts of Ziziphus spina-christi. Caffeic acid was the most predominant phenolic, while quercetin, luteolin, taxifolin, and isoquercetin were common flavonoids in the fruits' ethyl acetate fraction. Key saponins identified include Lotoside II, Ziziphus saponin I, and betulinic acid.
Potent In Vitro Antiviral Activity
The crude leaf extract of Ziziphus spina-christi demonstrated the highest anti-SARS-CoV-2 activity (IC50 7.4 µg/ml, SI 45.9) and potent anti-H1N1 activity (IC50 1.240 µg/ml, SI 304.0). The residual leaf extract showed the highest anti-MERS-CoV activity (IC50 1.5 µg/ml, SI 371.0). Furthermore, the hexane fruit extract exhibited high anti-MERS-CoV activity (IC50 1.9 µg/ml, SI 70.1) and anti-H1N1 activity (IC50 1.7 µg/ml, SI 358.0).
Virucidal Effect and Molecular Docking Insights
All tested extracts showed significantly higher virucidal activity (up to 95% inhibition) compared to adsorption and replication inhibition, suggesting direct viral inactivation. Molecular docking identified Lotoside II and Hydroxygenistein methyl ether malonylhexoside as key inhibitors. Lotoside II demonstrated strong binding to H1N1 HA (-7.48 kcal/mol), H1N1 NA (-8.00 kcal/mol), MERS-CoV spike (-8.19 kcal/mol), and SARS-CoV-2 spike (-10.18 kcal/mol).
1.240 µg/ml
Highest Antiviral IC50 (H1N1 Crude Leaf Extract)
Enterprise Process Flow
Plant Material Collection & Preparation
→
Crude Methanol Extraction
→
Fractionation (n-hexane, DCM, EtOAc, Aqueous)
→
LC-ESI-MS/MS Chemical Profiling
→
In Vitro Antiviral Assays (CC50, IC50)
→
Mode of Action Study (Virucidal, Adsorption, Replication)
→
In Silico Molecular Docking
| Compound | HA (H1N1) Binding (kcal/mol) | NA (H1N1) Binding (kcal/mol) | MERS-CoV Spike Binding (kcal/mol) | SARS-CoV-2 Spike Binding (kcal/mol) |
|---|---|---|---|---|
| Lotoside II | -7.48 | -8.00 | -8.19 | -10.18 |
| Hydroxygenistein methyl ether malonylhexoside | -6.79 | -7.72 | -8.27 | -8.84 |
Z. spina-christi: A New Horizon for Antiviral Drug Discovery
Egyptian Ziziphus spina-christi (Nabq tree) has been used for centuries in traditional medicine. This study provides strong scientific evidence for its potent antiviral activities against major respiratory viruses including H1N1, MERS-CoV, and SARS-CoV-2. Its rich profile of bioactive compounds, particularly Lotoside II and Hydroxygenistein methyl ether malonylhexoside, offers a natural, potentially cost-effective source for novel antiviral drug candidates. The identified virucidal mechanism suggests direct viral inactivation, a critical advantage in early infection stages.
Calculate Your Potential ROI
Estimate the efficiency gains and cost savings by leveraging AI-driven insights in your enterprise.
Annual Cost Savings
$0
Annual Hours Reclaimed
0
Your AI Implementation Roadmap
A structured approach to integrating AI, from discovery to full-scale deployment and continuous optimization.
Phase 1: Discovery & Strategy
Initial consultation to understand your business objectives, current challenges, and identify high-impact AI opportunities. Develop a tailored strategy and define clear success metrics.
Phase 2: Data Preparation & Model Development
Collect, clean, and preprocess relevant data. Design, train, and validate custom AI models based on your specific requirements and strategic goals.
Phase 3: Integration & Pilot Deployment
Seamlessly integrate AI solutions into your existing systems and workflows. Conduct a pilot program to test functionality, gather feedback, and refine performance in a live environment.
Phase 4: Scaling & Optimization
Full-scale deployment across your enterprise. Continuous monitoring, performance tuning, and iterative improvements to ensure maximum ROI and adaptation to evolving needs.
Ready to Transform Your Enterprise with AI?
Book a complimentary 30-minute strategy session with our AI experts to explore how these insights can be tailored to your business challenges and opportunities.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat